Longeveron Names Jerome Bailey Vice President of Business Operations

2 years ago

Executive brings more than 30 years of global biopharmaceutical operations and program management experienceMIAMI, Sept. 15, 2022 (GLOBE NEWSWIRE) --…

Sienna Announces September Dividend

2 years ago

MARKHAM, Ontario, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced…

WIMI Hologram Academy: Mobile Edge Intelligence and Computing for Internet of Vehicles

2 years ago

HONG KONG, Sept. 15, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

Palisade Bio Streamlines Operations and Identifies Capital Efficiencies to Focus All Resources on Advancement of Lead Clinical Program, LB1148

2 years ago

CARLSBAD, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for…

Tenax Therapeutics Announces the Evaluation of Strategic Alternatives

2 years ago

MORRISVILLE, N.C., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying,…

Surgalign Announces Third Clinical Site in the Commercialization of its HOLO Portal™ Surgical Guidance System

2 years ago

Dr. Jaideep Chunduri of Beacon Orthopedics & Sports Medicine in Cincinnati, OH utilizes HOLO Portal, the world’s first artificial intelligence…

Celsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer

2 years ago

110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy Alone LAWRENCEVILLE, N.J., Sept. 15,…

Ashvattha Therapeutics Announces Presentations of Preclinical Data on Hydroxyl Dendrimer-Based PET Tracer [18F]OP-801 at the 2022 World Molecular Imaging Congress (WMIC)

2 years ago

– Scientific collaborators at Stanford University will present data on an imaging and treatment regimen demonstrating the microglial targeting of…

Syapse Enters Collaboration with Merck Using Real-World Evidence to Better Understand Cancers

2 years ago

SAN FRANCISCO and NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing…

Daré Bioscience to Participate in Two Upcoming Conferences

2 years ago

SAN DIEGO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today…